PhD neuroscientist | Biomedical data scientist Pain, biomarkers, and large-scale human data

Montréal, Québec
Joined December 2011
Smoking, obesity, and household income explained an important but incomplete share of pain burden. Their effects were also site-specific, and they explained much less of the burden in some lower-HDI regions.
1
27
We also built an open-access benchmarking tool so researchers can compare their cohorts against the global reference curves: evppainlab.shinyapps.io/glob… Huge thanks to our collaborators, data partners, participants, and @evp82 !
1
29
A performance atlas of six commercial high-throughput proteomics platforms across 10 dimensions. Awesome resource for guiding the selection of the right platform for different research projects.
1
6
31
1,871
Matt Fillingim retweeted
In a genome-wide association analysis of fibromyalgia across 2.5M, the top signal was a coding variant in HTT, part of the common Huntington's Disease germline risk haplotype A1 nature.com/articles/s41591-0… @NatureMedicine
2
21
1
123
10,914
Matt Fillingim retweeted
Brain–body-environment interactions must move beyond isolated exposures toward the expotype: the dynamic configuration of physical, social, lifestyle, and internal factors that jointly shape brain–behaviour phenotypes. At @NatRevNeurosci (nature.com/articles/s41583-0…), we propose a future agenda to assess the exposome as a complex, time-varying system that requires nonlinear models to capture interactions, thresholds, synergistic effects, and cross-domain buffering mechanisms. Although predictive machine learning can support individual risk estimation, the next frontier is to move from prediction to mechanism, from association to dynamic synergetic inference. Multivariate learning, causal machine learning, aging clocks, longitudinal designs, and generative biophysical digital twins are beginning to provide this bridge. Brain–body–environment diversity can reveal how ecology becomes biologically embedded. We call for a future exposomic neuroscience that integrates nonlinear temporal modeling, generative mechanisms, and population diversity to understand, simulate, and modify trajectories of brain aging and disease. Congrats Sarah Genon, @MasoudTahmasian & @INM7_ISN
1
79
2
283
20,720
🛠️ We built all of this into an open-access benchmarking tool, where you can compare any external cohort against the global reference: evppainlab.shinyapps.io/glob…
1
1
44
🙏 Huge thanks to the 100+ co-authors and data partners who made this possible, and to @EtienneVP and the lab at @McGillU.
43
Working with 894 surveys and cohorts spanning every inhabited continent and ages 5 to 100, we mapped pain at 11 anatomical sites plus high-intensity and generalised pain. A couple findings below:
37
New paper w/ @_LeeJaeJoong_ in Nat Neurosci!🧠 We developed personalized fMRI predictive models tracking ongoing spontaneous pain in chronic pain patients, trained on 6+ mo. of densely sampled data. A true team effort. Deeply grateful to our participants! doi.org/10.1038/s41593-026-0…
4
36
1
103
6,068
Yes, been saying/doing this for years .. publish when you have a complete story that is fully vetted, and preprint along the journey I constantly get comments “this could’ve been 4-5 papers”; like no, you weren’t gonna read all that. Here is the whole picture in front of you
The way to accelerate science is to SLOW it down. Fewer papers please! We’re drowning in meaningless text. One GREAT paper per lab per decade is more than enough. q.e.d 👇
1
2
16
2,111
Matt Fillingim retweeted
Phenotyping is the vast, minimally-explored frontier in genome-wide association studies. Important thread🧵 Briefly, phenotyping is how you measure people's traits. Measure poorly, get bad results; measure well, get good results. Example? Janky knees.
12
32
6
426
186,117
Matt Fillingim retweeted
Benchmarking methods for mapping functional connectivity in the brain | doi.org/10.1038/s41592-025-0… What is the best FC metric? led by @liuzhenqi0303 in @naturemethods ⤵️
2
78
2
251
18,080